With a foundation in cell culture that dates back to 1970, FUJIFILM Biosciences is a global, full spectrum supplier to the life sciences market, providing products and services that assist customers in advancing healthcare initiatives. With an expanding portfolio of applications supported that include life science and discovery research, cell and gene therapy, as well as the large-scale production of biotherapeutics and vaccines, the Company is trusted by researchers and manufacturers worldwide.
For over 50 years, FUJIFILM Biosciences’ Mission has been to empower all who bring medicines and treatments to life with unmatched quality and responsiveness in its products and custom solutions, providing customers with the vital resources needed to enrich human lives through innovative, accessible therapies. The Company’s facilities adhere to both ISO and FDA regulations, with manufacturing facilities that follow cGMP guidelines in the USA, Japan, and the Netherlands, and a media optimization center in China.
All sites prioritize strategies that adhere to the FUJIFILM Sustainability Value Plan 2030 for sustainable growth. FUJIFILM Biosciences is a subsidiary of FUJIFILM Holdings America Corporation reporting to FUJIFILM Holdings Corporation.
For more information, please visit: fujifilmbiosciences.fujifilm.com
FEATURED INSIGHTS
-
Predicting The Performance Of Perfusion Media In A Continuous Bioreactor
Small-scale perfusion-mimic models can effectively predict media performance in continuous bioreactors to help optimize cell density, productivity, and scalability for CHO cell lines.
-
High-Throughput Screening For High-Performance Cell Culture Media Development
Learn about a high-throughput screening method that successfully optimized cell culture media, leading to a greater than 3-fold improvement in viral genome titer for AAV2 production.
-
Innovative Strategies For Developing And Enhancing Perfusion Platforms
Discover how to effectively use small-scale perfusion-mimic systems to identify optimal cell culture media and significantly increase volumetric productivity for large-scale biomanufacturing.
-
Scalable Strategies For Intensified Viral Vector Production In HEK293 Cell Culture
Learn a strategy for scalable bioprocessing and media optimization that drives intensified viral vector production. Achieve high cell density, excellent viability, and consistent AAV titers from 50mL to 5L.
-
Chemically Defined HEK293 Viral Feed Boosts Viral Vector Production
Discover how a chemically defined viral feed can boost AAV titers by up to 8-fold, supporting multiple serotypes and both suspension and adherent HEK293 cell lines, simplifying scalability.
CONTACT INFORMATION
FUJIFILM Biosciences
1830 E. Warner Avenue
Santa Ana, CA 92705-5505
UNITED STATES
Phone: 949-261-7800
Fax: 949-261-6522
NEWS
SOLUTIONS
Achieve A New Level Of Viral Vector Productivity
Maximize your viral vector output with a chemically defined medium engineered for high cell density HEK293 perfusion and intensified processes, optimizing efficiency and product integrity.
-
This xeno- and serum-free media and supplement pairing provides consistent, high-yield expansion of MSCs from various tissue sources while maintaining their critical phenotype.